Trials / Conditions / Bone Metastatic Castration-resistant Prostate Cancer
Bone Metastatic Castration-resistant Prostate Cancer
4 registered clinical trials studyying Bone Metastatic Castration-resistant Prostate Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study to Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have N NCT04587427 | Bayer | — |
| Completed | A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the NCT04521361 | Bayer | Phase 1 |
| Completed | Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer NCT02204943 | Duke University | EARLY_Phase 1 |
| Completed | Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer NCT01074138 | Athenex, Inc. | Phase 2 |